Abstract
The delineation of renal disease in children dates to the 1880s with descriptions of Henoch’s purpura, bladder exstrophy, renal rickets and nephritis. The discipline of pediatric nephrology mainly emerged during the 20th century in response to problems in fluid and electrolyte balance, characterization of the nephrotic syndrome, use of renal biopsy, antibiotic therapy of urinary tract infections, dialysis and transplantation in children, growth problems associated with chronic renal failure, detection and therapy of hypertension, and the creation of both national and international pediatric nephrology societies and a journal now in its 18th year. The development of molecular and cell biology, genetic and genomic techniques and bioinformatics methods underlie many future directions. We should anticipate further elucidation of single gene disorders, of complex trait analysis of disorders, such as diabetic nephropathy and hypertension, the interplay of developmental genes and gene products and interactions within the podocyte. Specific therapies directed against inflammation, vascular damage, cyst development, the ravages of proteinuria and graft rejection (or induction leading to tolerance) will be developed. Stem cell therapies may replace lost renal mass, even of specific nephron sites. Novel therapies will also modulate the cell cycle, tyrosine kinase signaling and apoptosis. In addition, drugs will be specifically tested in children for many renal conditions. Larger and more specialized registries will be developed; epidemiologic studies and exploration of large data sets will lead to clinical guidelines that are evidenced-based. There is a need for more careful measurement of glomerular filtration rate (GFR), proteinuria and cytokines, and a fuller appreciation of the nutritional and hormonal role of the kidney. Finally, the antecedents of adult renal disease and the need to intervene in a proactive fashion will be realized. Despite these impressive advances in care, the greatest challenges will be in providing children with renal disease access to well-trained pediatric nephrologists, especially in Asia (1 billion children), Africa, Central and South America, and in immigrant and refugee populations. Included in this challenge is the capacity to have affordable access to use of contemporary techniques, and effective medications and prevention strategies. The International Pediatric Nephrology Association (IPNA), its journal, and pediatric advocates will need to use their energies to take on these challenges.
Similar content being viewed by others
References
Machiavelli N (1950). The Prince and the discourses, (translated by Ricci L). McGraw Hill, p 21
Dingle CA (2000) Memorable quotations: Philosophers of Western civilization: Baruch Spinoza. Writers Club Press
Chesney RW (2003) The failure of Ockham’s razor in 21st century pediatrics. Pediatrics 55:903–907
Gruskin A, Williams RG, McCabe ER, Stein F, Strickler J, Mulvey HF, Alden ER, Simon JL, Chesney RW (2000) Final report of the FOPE II Pediatric Subspecialists of the Future Workgroup. Pediatrics 106:1224–1244
Federation of Pediatric Organizations (2004) Policy statement: Pediatric fellowship training. Pediatrics 114:295–296
(2000) Seventh Asian Congress of Pediatric Nephrology, Singapore
(2004) 21st World Congress of the International Pediatric Association, Cancun, Mexico
Chesney RW (2002) The history of pediatric discipline series. A history of pediatric specialties: the development of pediatric nephrology. Pediatr Res 52:770–778
Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB (2003) Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol 18:833–837
Chesney RW, Christensen ML (2004) Changing requirements for evaluation of pharmacologic agents. Pediatrics 113 [Suppl 4]:1128–1132
Institute of Medicine (2004) Ethical conduct of clinical research involving children
Schieppati A, Remuzzi G (2004) Fighting renal diseases in poor countries: Building a global fund with the help of the pharmaceutical industry. J Am Soc Nephrol 15:704–707
Eddy AA (2000) Molecular basis of renal fibrosis. Pediatr Nephrol 15:290–301
Goldstein SL (2004) Adequacy of dialysis in children: Does small solute clearance really matter? Pediatr Nephrol 19:1–5
Challen GA, Martinez G, Davis MJ, Taylor DF, Crowe M, Teasdale RD, Grimmond SM, Little MH (2004) Identifying the molecular phenotype of renal progenitor cells. J Am Soc Nephrol 15:2344–2357
Eccles MR (1998) The role of PAX2 in normal and abnormal development of the urinary tract. Pediatr Nephrol 12:712–720
(2004) Ninth International Developmental Pediatric Workshop. Borassa Valley, Australia
Palevsky PM (2004) Acute renal failure. ASN: Nephrology Self-Assessment Program (NephSAP) 3:245–249
Salusky IB, Goodman WG, Kuizon BD (2000) Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism. Pediatr Nephrol 14:641–645
Kaskel F, Chesney RW, Goligorsky M (2003) Chronic renal disease: A growing problem. Kidney Int (Nephrology Forum) 64:1141–1151
Hollenberg NK (2004) Aldosterone in the development and progression of renal injury. Kidney Int 66:1–9
Bascands JL, Schanstra JP (2004) Bradykinin and renal fibrosis: Have we ACE’d it? J Am Soc Nephrol 15:2504–2506
Nagata M, Tomari S, Kanemoto K, Usui J, Lemley KV (2003) Podocytes, parietal cells, and glomerular pathology: The role of cell cycle proteins. Pediatr Nephrol 18:3–8
Besbas N, Ozaltin F, Coskun T, Ozalp S, Saatci U, Bakkaloglu A, El Nahas AM (2003) Relationship of leptin and insulin-like growth factor I to nutritional status in hemodialyzed children. Pediatr Nephrol 18:1255–1259
Mitch WE (2002) Malnutrition: A frequent misdiagnosis for hemodialysis patients. J Clin Invest 110:437–439
Author information
Authors and Affiliations
Corresponding author
Additional information
Final keynote lecture at the 15th Congress of the International Pediatric Nephrology Association, Adelaide, Australia, August, 2004
Rights and permissions
About this article
Cite this article
Chesney, R.W. The future of pediatric nephrology. Pediatr Nephrol 20, 867–871 (2005). https://doi.org/10.1007/s00467-005-1902-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-005-1902-0